Dr. Amit Singal, MD, of UT Southwestern Medical Center in Dallas, provides an overview of
fatty liver disease and discusses the increasing role of fatty liver disease as a cause of liver cancer. Fatty liver disease is also called
non-alcoholic fatty liver disease, or a newer term,
metabolic dysfunction-associated steatotic liver disease (
MASLD). As fat buildup from MASLD damages the liver, a more serious condition called
metabolic-associated steatohepatitis (
MASH), can develop. As obesity, diabetes, and alcohol use have become more prevalent, so too have cases of fatty liver disease. This condition can lead to chronic liver inflammation, cirrhosis, and ultimately liver cancer. Dr. Singal highlights the importance of recognizing and addressing fatty liver disease, given its growing role in liver cancer incidence in the modern era.
-
Share with family and friends:
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about liver cancer which will help other patients, caregivers, and families.